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ABSTRACT
Post-transcriptional regulation of mRNA during oxygen deprivation, or hypoxia, can affect the survivability of cells. Hypoxia has
been shown to increase stability of a subset of ischemia-related mRNAs, including VEGF. RNA binding proteins and miRNAs have
been identified as important for post-transcriptional regulation of individual mRNAs, but corresponding mechanisms that regulate
global stability are not well understood. Recently, mRNA modification by N6-methyladenosine (m6A) has been shown to be
involved in post-transcriptional regulation processes including mRNA stability and promotion of translation, but the role of
m6A in the hypoxia response is unknown. In this study, we investigate the effect of hypoxia on RNA modifications including
m6A. Our results show hypoxia increases m6A content of poly(A)+ messenger RNA (mRNA), but not in total or ribosomal RNA
in HEK293T cells. Using m6A mRNA immunoprecipitation, we identify specific hypoxia-modified mRNAs, including glucose
transporter 1 (Glut1) and c-Myc, which show increased m6A levels under hypoxic conditions. Many of these mRNAs also
exhibit increased stability, which was blocked by knockdown of m6A-specific methyltransferases METTL3/14. However, the
increase in mRNA stability did not correlate with a change in translational efficiency or the steady-state amount of their
proteins. Knockdown of METTL3/14 did reveal that m6A is involved in recovery of translational efficiency after hypoxic stress.
Therefore, our results suggest that an increase in m6A mRNA during hypoxic exposure leads to post-transcriptional
stabilization of specific mRNAs and contributes to the recovery of translational efficiency after hypoxic stress.
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INTRODUCTION
Hypoxia is a metabolic condition that occurs when oxygen
levels are deficient in cells or tissues. This stress can occur
during embryonic development, where crowding and rapid
cell division causes a shortage of blood and oxygen supply
(Keith and Simon 2007; Mazumdar et al. 2009). Hypoxia
can also be brought on by impaired blood flow due to heart
attack or stroke (Semenza 2014a; Ferdinand and Roffe 2016).
Other diseases can affect oxygen delivery including sickle
cell disease and low blood pressure, which create hypoxic
environments within the tissues. Regardless of the origins
of the hypoxic stress, cells must alter their metabolism and
gene expression in ways that will increase their chance of sur-
vival, or succumb to apoptosis. The physiological response to
hypoxia is initiated by the stabilization of the hypoxia-induc-
ible factor-1α (HIF-1α) transcription factor targeting genes
containing a hypoxia response element (HRE) (Wenger
et al. 2005; Lokmic et al. 2012; Hong et al. 2014; Semenza
2014b). HIF-1α is also important for promoting cancer cell
survival through interactions with Myc and Jun, and it is
well documented that hypoxia drives tumor angiogenesis
(Harris 2002; Laderoute et al. 2002; Nelson et al. 2004;
Dang et al. 2008; Rankin and Giaccia 2008; Li et al. 2009;
Foster et al. 2014). HIF-1α directly stimulates the transcrip-
tion of vascular endothelial growth factor (VEGF). This hall-
mark of the hypoxic response leads to increased translation of
VEGF promoting vascular growth in order to increase the
blood supply to affected cells, thereby leading to increased
oxygen (Levy 1998; Levy et al. 1998; Stein et al. 1995;
Arcondéguy et al. 2013). The hypoxic response also aids
tumor migration by up-regulating the genes that are involved
in the degradation of the extracellular matrix, as well as
increasing the metastatic ability of the tumor and cellular
proliferation through genes such as dual specificity protein
phosphatase 1 (Dusp1) and hairy and enhancer of split 1
(Hes1) (Wykoff et al. 2001; Harris 2002; Giatromanolaki
et al. 2003; Rankin and Giaccia 2008; Zou et al. 2013;
Balamurugan 2015; Gao et al. 2015; Shen et al. 2016).
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Because the hypoxic response is so important to cancer cell
survival, it is critical to fully understand all mechanisms
occurring during hypoxia, including post-transcriptional
regulation.
Although the transcriptional response to hypoxia is well
established, the post-transcriptional response to oxygen
deprivation is less understood. Post-transcriptional responses
often regulate mRNA splicing and stability, and the stability
of individual mRNAs, such as VEGF and Glut1, is increased
with hypoxic exposure (Paulding and Czyzyk-Krzeska 2000).
We have recently expanded upon these studies and identified
numerous mRNAs stabilized in response to oxygen and glu-
cose deprivation, including VEGF, Myc, Hes1, Jun, and
Dusp1 (Carraway et al. 2017). Specific sequences in VEGF
mRNA 3′ UTR and ORF have also been discovered to
contribute to the stabilization of VEGF in response to hypox-
ia, but this analysis has not been extended to other mRNAs
(Levy 1998; Levy et al. 1997, 1998; Dibbens et al. 1999;
Goldberg-Cohen et al.2002). It has also been well document-
ed that severe oxygen deprivation leads to inhibition of
global cap-dependent translation, but post-transcriptional
regulation of a subset of mRNAs allows for continued trans-
lation through a number of proposed mechanisms (Liu and
Simon 2004; van den Beucken et al. 2006; Young et al.
2008; Fähling 2009a,b; Uniacke et al. 2012). The hypoxic
response has also recently been implicated in global changes
in alternative splicing (Hu 2014; Sena et al. 2014). Thus, it is
clear that post-transcriptional regulation of mRNAs has a
role in the hypoxic response, but the mechanisms involving
this regulation have not all been identified.
Recently, m6A mRNA modification has been shown to
be important for the stability and translational efficiency of
mRNA (Wang et al. 2014a, 2015; Du et al. 2016; Li et al.
2017; Shi et al. 2017). m6A methylation is a post-transcrip-
tional modification of mRNA occurring in the nucleus (Lee
et al. 2014; Liu et al. 2014; Ping et al. 2014). The m6A meth-
yltransferase complex consists of methyltransferase like-3
and -14 (METTL3 and METTL14), as well as Wilms’ tumor
associating protein (WTAP) (Agarwala et al. 2012; Liu et al.
2014; Ping et al. 2014). METTL3 contains an S-adenosyl
methionine (SAM) binding domain, and utilizes SAM as a
substrate to methylate target mRNAs that contain a
DRACH m6A consensus sequence, often found in 3′ UTR’s
and around stop codons (Meyer et al. 2012; Liu et al.
2014), while METTL14 lacks catalytic activity but participates
in mRNA binding/targeting (Sĺedz ́ and Jinek 2016; Wang
et al. 2016a,b). m6A methylation of RNA is reversible and
can be removed by alkylation repair homolog 5 (ALKBH5)
or fat mass and obesity related protein (FTO) (Jia et al.
2011, 2013; Fu et al. 2013, 2014; Zheng et al. 2013; Liu
and Jia 2014; Meyer and Jaffrey 2014; Xu et al. 2014a).
Methylated mRNA is transported out of the nucleus and
bound by RNA binding proteins, including most members
of the YTH family (Dominissini et al. 2012; Wang et al.
2014a; Xu et al. 2014b). While much is known about the
mechanisms of m6A writing and erasing, the broader conse-
quences of RNA methylation are still being investigated. m6A
methylation has been shown tomark mRNA for degradation,
mediated by YTHDF2 transport to P bodies where degrada-
tion of mRNA occurs (Fu et al. 2014; Schwartz et al. 2014;
Wang and He 2014; Wang et al. 2014a). Additionally,
YTHDF1 has recently been reported to stimulate translation-
al efficiency of m6A methylated mRNA, thereby increasing
translational output (Wang et al. 2015).
It is known that through post-transcriptional regulation,
the fate of mRNAs can change based on the changing condi-
tions of the cell (Mansfield and Keene 2009). Post-transcrip-
tional modifications like m6A may alter the fate of RNA by
potentially altering secondary structure, the ability of RNA
binding proteins to bind, or the position of splicing events
(Karijolich et al. 2010; Liu et al. 2015; Roost et al. 2015;
Theler and Allain 2015; Zhou et al. 2016). Changes at the
RNA level can occur rapidly and are necessary to adapt to
rapidly changing microenvironments. RNA modifications
can also direct permanent changes within the cell, as is the
case of m6A modifications that limit the pluripotency of
embryonic stem cells (Wang et al. 2014b; Geula et al. 2015;
Zhao and He 2015). Defects in these post-transcriptional
modifications could cause problems in rapid cell response
mechanisms, embryonic development, or even promote
tumor growth.
m6A mRNA has received much attention in recent years,
allowing the factors involved in m6A mRNA methylation to
be identified. However, the importance of dynamic mRNA
methylation has remained elusive. Recently, roles for m6A
mRNA in the pluripotency of stem cells in embryonic devel-
opment (Wang et al. 2014b; Geula et al. 2015; Zhao and He
2015), as well as the induction of a cancer stem cell pheno-
type in breast cancer cells, has been described (Aguilo et al.
2015; Zhang et al. 2016). However, the m6A modification
may function in other responses, including adaptation to
changing cellular environments. Therefore, it is quite possi-
ble that the m6A modification may be involved in post-tran-
scriptional hypoxic response mechanisms. Understanding
the shifting landscape of m6A mRNA in hypoxic cells will
shed light on not only how post-transcriptional regulation
is altered when oxygen is lacking, but also the extent of
m6A post-transcriptional utilization within a cell under other
dynamic conditions.
RESULTS
Effect of hypoxia on cellular RNA modification levels
Changes in the m6Amodification of mRNA have been shown
to regulate stem cell pluripotency during embryonic develop-
ment as well as breast cancer stem cell phenotypes. We inves-
tigated whether a cellular stress that is present in both of these
models, hypoxia, has any effect on RNA modification levels,
including m6A. To do this, HEK293T cells were incubated for
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24 h under normoxic or hypoxic (1% O2) conditions in the
presence of 1 g/L glucose to mimic the nutrient deprivation
encountered during ischemic events. Poly(A)+ mRNA was
enriched by oligo(dT) selection followed by ribosomal
RNA (rRNA) depletion (verified by qPCR) (Supplemental
Fig. 1A), and after fragmentation, liquid chromatography
and tandem mass spectrometry (LC-MS/MS) were used to
quantify various RNA modifications in the mRNA enriched
samples. Surprisingly, in contrast to a recent report measur-
ing m6A in total RNA and specific mRNAs in breast cancer
cells (Zhang et al. 2016), global poly(A)+ RNA showed a
significant increase in m6A content in HEK293T cells ex-
posed to hypoxia (Fig. 1A). Other mRNA modifications, in-
cluding 5-methylcytidine, showed no significant differences
in hypoxia (Supplemental Fig. 2). These
data show that the mRNA modification,
m6A, has a dynamic response to hypoxia.
As mRNA makes up <10% of the
cellular RNA mass, we postulated that
hypoxia may cause changes in modi-
fications in other RNA species as well.
We tested this hypothesis by first measur-
ing RNA modifications in total RNA.
Surprisingly, in HEK293T cells m6A
levels in total RNA were unchanged in
hypoxia (Fig. 1B). However, 5-methylcy-
tidine andN1-methylguanosine were sig-
nificantly decreased (Supplemental Fig.
3). Because rRNA makes up 80%–85%
of the cellular RNA mass, we postulated
that modifications with diminished con-
tent in total RNA derived chiefly from
changes in rRNA modifications. Thus,
40 and 60S ribosomal subunits were
isolated via differential centrifugation
through sucrose gradients. rRNAwas iso-
lated from the fractions and subjected to
qPCR to verify the composition of the
fractions (Supplemental Fig. 1B). Again,
LC-MS/MS revealed no change in m6A
content from either 18S or 28S rRNA in
HEK293T cells exposed to hypoxia (Fig.
1C). However, similarly to total RNA,
5-methylcytidine exhibited a statistically
significant decrease in content in 18S
RNA, andN1-methylguanosine exhibited
a decreasing trend in 18S RNA as well
(Supplemental Fig. 4). Interestingly,
pseudouridine also exhibited a decrease
in content in the isolated 28S rRNA, but
no changes were detected in total RNA
(Supplemental Figs. 3, 4). These results
suggest that not only mRNA modifica-
tions, but also specific rRNA modifica-
tions, are dynamically altered after 24 h
of hypoxic conditions. However, for this studywe chose to fo-
cus on the effects of hypoxia on the mRNAm6A content, giv-
en its reported effects on mRNA regulation.
Identification of differentially methylated mRNAs
Given that we saw dynamic changes in the m6A content of
mRNA, we next wanted to determine whether m6A methyl-
ation of specific mRNA targets involved in the adaptive
response was affected when cells were exposed to hypoxia.
Using m6A RNA immunoprecipitation (MeRIP), target
mRNAs related to hypoxia and tumorigenesis including
Glut1, Jun, Myc, Dusp1, and Hes1 were investigated.
















































































FIGURE 1. Hypoxia increases m6A in poly(A)+ RNA but not in total or ribosomal RNA. RNA
isolated from HEK-293T cells grown in normoxic (Normox) or hypoxic (Hypox) conditions for
24 h. (A) LC-MS/MS of mRNA from HEK-293T cells. Values represent the amount of m6A di-
vided by total adenosine (N of 3). (∗) P≤ 0.05 by paired Student’s t-test. Error bars represent stan-
dard error of the mean (SEM). (B) LC-MS/MS of total RNA from HEK-293T cells. Values
represent the amount of m6A divided by total adenosine (N of 2). (C) LC-MS/MS of 18 and
28S rRNA from HEK-293T cells. Values represent the amount of m6A divided by total adenosine
(N of 3). (D) MeRIP of 100 ng of mRNA from HEK-293T cells grown in normoxic or hypoxic
conditions for 24 h quantified by qRT-PCR. Fold enrichments calculated from immunoprecip-
itated mRNA levels normalized to input and bead-only negative control IP and expressed as a ra-
tio of hypoxia/normoxia. (∗) P≤ 0.05 by paired Student’s t-test. Error bars represent SEM of five
experiments.
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and poly(A) mRNA isolated via oligo(dT) selection and ribo-
minus treatment. m6A containing mRNAs were then immu-
noprecipitated using an m6A-specific antibody. Following
cDNA synthesis, the relative enrichment of the indicated
mRNAs was determined using qPCR. The targets were quan-
tified relative to input RNA and the negative IP. Interestingly,
many of the hypoxia-associated and tumorigenic mRNAs
from hypoxic cells, including Glut1 and Jun, increased
more than twofold in the m6A captured fraction, as com-
pared to the normoxic conditions (Fig. 1D). This signifies
an increase in the m6A content of these mRNAs in response
to hypoxic exposure. It is likely that these and other mRNAs
contribute to the enhanced m6A content of poly(A)+ RNA
(Fig. 1A). Importantly, mRNAs such as human antigen R
(HuR) and METTL3 showed no change in m6A content
(Fig. 1D), suggesting that this was not a global phenomenon,
but rather a directed change.
Loss of m6A prevents hypoxic mRNA
stabilization
To address if m6A methylation plays a
role in stabilization of these particular
mRNAs as part of their post-transcrip-
tional response to hypoxia, METTL3
and METTL14 of the m6A methyltrans-
ferase complex were knocked down
via siRNA and the half-lives of our target
mRNAs were determined. Knockdown of
METTL3 and METTL14 was confirmed
via Western blot analysis (Fig. 3B).
Depletion of m6A content in individual
mRNAs was confirmed by MeRIP
followed by qPCR (Supplemental Fig.
5). After depletion of METTL3 and
METTL14 for 48 h, HEK293T cells
were transferred to either normoxic or
hypoxic conditions for 24 h to simulate
ischemia. During the last hour of
treatment, newly transcribed RNA was
metabolically labeled using 4-thiouridine
(4sU). RNA was harvested, the 4sU
labeled RNA was biotinylated, and strep-
tavidin beads were used to separate the
new labeled RNA from unlabeled RNA.
RNA half-lives were determined from
the ratio of the labeled to unlabeled
RNA normalized to total RNA. As shown
in Figure 2, many of the mRNAs that had
increased m6A methylation in hypoxic
conditions (Glut1, Jun, Dusp1, and
Hes1) also showed a significant increase
in mRNA half-life. Interestingly, knock-
down of METTL3/14 had no effect on
the normoxic half-life of any of the
mRNAs, but loss of the methyltransferases did significantly
inhibit their hypoxic stabilization. eEFA1, which exhibited
no change in m6A level (data not shown) also showed no
loss of stabilization after METTL3/14 depletion. Therefore,
mRNAs that were stabilized under hypoxic conditions lost
that stabilization after an engineered decrease in m6A levels.
This suggests that enhanced m6A modification of specific
mRNAs can indeed affect their hypoxic post-trasnscriptional
regulation.
The effect of m6A on mRNA translation
and protein levels
Having determined that changes in m6A content affected
mRNA stabilization, we next examined how methylation
might affect the translation of these messages. HEK293T cells
were again depleted of METTL3/14 for 48 h, and transferred
to either normoxic or hypoxic conditions for 24 h followed




























































































































FIGURE 2. Individual mRNAs are stabilized under hypoxia in anm6A-dependent manner. Total
RNA fromHEK-293T cells was harvested after 72 h transfection withMETTL3/14 siRNA (M3/14
siRNA) or negative control siRNA (Neg siRNA) and 24 h of normoxic or hypoxic conditions and
half-life determined via 4sU. (#) denotes P≤ 0.05 by paired Student’s t-test between negative
siRNA samples in normoxic and hypoxic conditions while (∗) denotes P≤ 0.05 by paired
Student’s t-test between negative and M3/14 knockdown siRNAs in the hypoxic condition.
Error bars represent SEM of five experiments.
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cellular extracts on sucrose gradients. Polysome profiles
(Supplemental Fig. 6A–D) were analyzed by qRT-PCR for
specific mRNA targets. Sedimentation position as shown by
polysome profiling allowed us to determine how efficiently
each message was being translated. During sucrose-gradient
resolution, mRNAs partition based on the number of ribo-
somes bound, which is a direct measure of their translational
efficiency. For example, mRNA such as β-2-microglobulin
(β2M), which is found to peak in fraction 8 in normoxic
conditions, is considered to be moderately translated, while
an mRNA that is primarily located in fractions 10 and 11,
such as Glut1, is bound heavily by polysomes, indicating
highly efficient translation (Fig. 3A). In general, hypoxic
exposure caused a decrease in translational efficiency (as in-
dicated by a leftward shift in the gradient) of assayed mRNAs.
The extent of the decrease depended on the mRNA being in-
vestigated. Surprisingly, depletion of m6A via METTL3/14
knockdown had no effect on the polysome loading of any
of the tested mRNAs, suggesting that m6A does not play a


























































































































NNeg NKD HNeg HKD NNeg NKD HNeg HKD
NNeg NKD HNeg HKD NNeg NKD HNeg HKD
NNeg NKD HNeg HKD NNeg NKD HNeg HKD
FIGURE 3. Translation rates and protein output are not affected by loss of m6A. HEK-293T cells harvested after 72 h transfection with METTL3/14
siRNA (M3/14 KD) or negative control siRNA (neg) and 24 h of normoxic (normox) or hypoxic (hypox) conditions. (A) Polysome profiling of ex-
tracts separated by differential centrifugation through sucrose gradients. qRT-PCR analysis of the fractions shows percentage of individual mRNA in
each fraction. Error bars represent SEM of three experiments. Fraction containing 80S peak is marked. (B) Western blots of 50 µg of protein lysates of
normoxic negative control siRNA (NNeg), normoxic METTL3/14 knockdown (NKD), hypoxic negative control (HNeg), hypoxic METTL3/14
knockdown (HKD) (representative of three experiments).
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To determine whether increased m6A during hypoxia was
involved in the recovery after hypoxia, polysome profiling
was used to determine translational efficiency after reoxygen-
ation of HEK293T cells with and without METTL3/14
knockdown. Polysome profiles were obtained similarly to
the previous experiments with the exception that cells were
exposed to room level oxygen for 0.5, 1, or 4 h prior to cyclo-
hexamide treatment and fractionation of cellular extracts on
sucrose gradients. Profiles (Supplemental Fig. 7) were again
analyzed by qRT-PCR for our specific
mRNA targets. After 4 h of reoxygena-
tion, recovery of translational efficiency
of Glut1, Jun, Dusp1, Hes1, and Myc
was diminished by METTL3/14 knock-
down compared to negative control
siRNA transfected cells (Fig. 4A;
Supplemental Fig. 8). These results sug-
gest that m6A may be aiding the cellular
response to recovery after stress.
All of the mRNAs shift from heavier to
lighter fractions in cells exposed to hyp-
oxic conditions; however, some mRNAs
shifted farther into lighter fractions
than others. For example, β2M and 18S
shift completely out of polysomes
into the subribosomal fractions 2–3.
However, Glut1 and Jun shifted only
moderately from heavy fractions, with
the majority of the mRNA being found
in fractions 5 through 7. This initially
suggested that Glut1 and Jun were still
being moderately translated under hyp-
oxia as has been previously reported
(Lai et al. 2016). However, it was also
possible that mRNAs such as Glut1 and
Jun had actually been released from the
translating ribosomes but were still in
large ribonucleoprotein complexes that
might also increase their sedimentation
in the gradient. To test whether the
mRNAs were still bound by intact ribo-
somes and hence translating, extracts
were treated with EDTA prior to sucrose
sedimentation (Supplemental Fig. 6E,F).
EDTA chelates the magnesium necessary
for large and small ribosomal subunit
association, releasing all mRNAs to
presumably sediment slower in their
nontranslating state. Interestingly, upon
EDTA release, normoxic β2M shifted
completely from heavy-to-light fractions
just as observed with hypoxia with
or without EDTA treatment (cf.
Supplemental Fig. 9 and Fig. 3A).
However, Glut1 and Jun only shifted
modestly from the heavier fractions to intermediate fractions,
despite being released from ribosomes. The sedimentation of
these mRNAs in intermediate fractions may indicate associ-
ation with previously uncharacterized ribonucleoprotein
complexes which are unaffected by EDTA metal chelation.
We attempted to correlate the mRNA translational effi-
ciency to the steady-state level of their protein products. If
m6A increases the stability of these mRNAs under hypoxic
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30min reoxy neg







NNeg NKD HNeg HKD Neg1 KD1 Neg2 KD2 Neg4 KD4 Neg8 KD8
NNeg NKD HNeg HKD Neg1 KD1 Neg2 KD2 Neg4 KD4 Neg8 KD8
NNeg NKD HNeg HKD Neg1 KD1 Neg2 KD2 Neg4 KD4 Neg8 KD8
NNeg NKD HNeg HKD Neg1 KD1 Neg2 KD2 Neg4 KD4 Neg8 KD8
FIGURE 4. METTL3/14 Knockdown decreased the ability of messages to recover from hypoxic
stress after 4 h reoxygenation. (A) HEK-293T cells harvested after 72 h transfection with
METTL3/14 siRNA (M3/14 KD) or negative control siRNA (neg) and 24 h of hypoxic conditions
and either 30 min, 1, or 4 h of room level reoxygenation recovery (reoxy). Polysome profiling of
extracts separated by differential centrifugation through sucrose gradients. qRT-PCR analysis of
the fractions shows percentage of individual mRNA in each fraction. Error bars represent SEM of
three experiments in the 1 and 4 h reoxygenation experiments and SEM of two experiments in the
30 min reoxygenation experiment. Fraction containing the 80S peak is marked. Paired Student’s
t-test indicates significant (P≤ 0.05) decrease (∗) or increase (#) compared to negative control
siRNA. (B) Western blots of 50 µg of protein lysates of normoxic negative control siRNA
(NNeg), normoxic METTL3/14 Knockdown (NKD), hypoxic negative control (HNeg), hypoxic
METTL3/14 Knockdown (HKD), and 1, 2, 4, or 8 h reoxygenation after hypoxia (representative
of three experiments).
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but maintains their translation, one might expect to see a
decrease in their protein after m6A knockdown. However,
Western blotting for these proteins under normoxia and
hypoxia after METTL3/14 knockdown showed no changes
in protein levels of Glut1, Myc, and Dusp1 (Fig. 3B). There
were also no observed changes in protein levels after reoxy-
genation even though polysome analysis suggested that
METTL3/14 knockdown decreased translational efficiency
after 4 h of recovery (Fig. 4B). This suggests that other factors
likely are involved in determining the steady-state levels
of proteins derived from these mRNAs. Interestingly,
METTL3/14 knockdown also had no significant effect on
HEK-293T cell proliferation under normoxic or hypoxic
conditions (Supplemental Fig. 10).
Summary
Our findings suggest that m6A mRNA methylation of certain
mRNAs is induced by hypoxia. Furthermore, increased m6A
prolongs the half-life of specific mRNA targets. Although the
increased stability of these messages did not correlate with
translational efficiency or changes in protein levels during
hypoxia, we found that loss of m6A through METTL3/14
knockdown decreased the cells’ ability to recover translation-
al efficiency after reoxygenation following hypoxic stress. We
also observed that under hypoxic conditions, some mRNAs
may be associated with other ribonucleoprotein complexes
instead of actively translating polysomes.
DISCUSSION
m6A has received renewed attention over the past few years as
a dynamic mRNA modification with many potential cellular
functions. Although the factors involved in m6A mRNA
methylation have been identified, the importance of mRNA
methylation remains unclear. We now suggest a role for
dynamic changes in mRNA m6A content in regulating
mRNA stability in response to oxygen deprivation. In contrast
to the total and rRNA, we saw a significant increase in them6A
content of mRNA levels in hypoxic cells, suggesting that the
m6A modification may be important for regulating mRNAs
in hypoxia. Our LC-MS/MS results did indicate the presence
of other dynamic RNA modifications in total and ribosomal
RNA after 24 h of hypoxia, but we have yet to identify what
the dynamic regulation of these modifications may signify.
Immunoprecipitation of m6A followed by qRT-PCR
allowed us to determine the m6A methylation status of indi-
vidual mRNAs. We observed an increase of m6A in specific
mRNA targets after hypoxic exposure. However, this method
cannot determine how hypoxia affects m6A methylation at
specific sites. In follow-up studies, we will seek to determine
whether hypoxia introduces m6A in new sites and if so, deter-
mine how specificity is regulated. It is possible that a hypoxic
switch in methylation sites, for example, switching methyla-
tion from the 5′ end to the 3′ end of the mRNA, could also
alter the regulation of the mRNAwithout affecting the overall
m6A level.
Others have previously reported that stability of individual
mRNAs was increased by hypoxia (Czyzyk-Krzeska et al.
1994; McGary et al. 1997; Levy et al. 1998; Paulding and
Czyzyk-Krzeska 2002; Carraway et al. 2017). It is also known
that m6A can affect the stability of mRNAs (Wang et al.
2014a,b). We now show that an increase in m6A methylation
is correlated with increased stabilization of a number of
mRNAs under hypoxic conditions. We confirmed the stabi-
lization of Glut1 and Myc mRNA under hypoxia (Chen et al.
2001; Carraway et al. 2017) but also identified several
novel targets including Dusp1, Hes1, and Jun. Interestingly,
these findings contradict suggestions that increased methyla-
tion leads to increased degradation of mRNAs through
YTHDF2 association (Zhang et al. 2016). The two data sets
are not directly comparable however, as stability of those
messages had not been reported under hypoxic conditions.
There are a number of possible reasons for this discrepancy.
Hypoxia may switch the location of themethylation, allowing
for different functions of the YTH family proteins, or equally
possible, an entirely different RNA binding protein may be
interacting with these hypoxically methylated mRNA. We
will attempt to probe these ideas in future studies.
Even thoughm6A increased the stability of certain mRNA’s
under hypoxic conditions, there was no noticeable effect on
translational efficiency or protein level. Polysome profiling
detected no substantial changes in translation between sam-
ples containing or lacking METTL3/14. Remarkably, even
though mRNA stability was increased, there was no detect-
able change in protein levels of Glut1, Myc, and Dusp1 as
determined by Western blotting. Interestingly, even though
METTL3/14 knockdown did not affect translation, hypoxia
itself caused a shift from heavier polysomes to a lighter com-
plex. This shift to lighter fractions was more robust in some
mRNAs than others. It was previously thought that this lack
of a complete shift out of polysomes ultimately indicated the
maintenance of translation. Indeed, it has previously been
reported that numerous mRNAs, including Hif-1α and
Glut1, continue to associate with polysomes during hypoxic
conditions (Thomas and Johannes 2007; Lai et al. 2016).
However, our data now suggest that these messages may be
being maintained in mRNPs that do not contain 80S ribo-
somes, based on their resistance to EDTA-mediated disrup-
tion of ribosome association. None of the previous reports
tested for this possibility.
Knockdown of METTL3/14 did decrease the ability of cells
to recover translational efficiency after 4 h of reoxygenation
following hypoxia. Detection of protein levels by Western
blotting after reoxygenation again showed little difference
with or without METTL3/14 KD, but polysome profiling
showed decreases in translational efficiency after 4 h of
reoxygenation in specific messages including Glut1, Hes1,
Dusp1, and Myc, suggesting that m6A’s role in hypoxia
may be related to recovery after the hypoxic stress rather
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than adaption to the stress. It is possible that the difference
between these two data sets is due to differences in protein
stability, or it is also possible that we could not detect these
subtle changes in protein levels accurately with Western blot-
ting. Utilizing a more physiologically relevant cell model or
investigating this phenomena in vivo might reveal situations
in which m6A exerts a more dramatic effect in the adaptation
to and recovery from hypoxic exposure.
Overall, this study demonstrates that hypoxic exposure can
indeed induce changes in multiple RNA modifications. In
particular, the m6A modification of mRNA is necessary for
increased stability under hypoxic conditions. Future studies
will explore these m6A changes with base-specific precision,
as well as the RNA binding proteins that interact with the
m6A modification under hypoxia. It is our goal to gain a
better understanding of mRNA dynamics in response to hyp-
oxia with the hope of developing new therapeutics targeting
cardiovascular disease, cancer and other diseases that involve
periods of reduced oxygen.
MATERIALS AND METHODS
Cell lines
HEK293T (HEK293T/17; CRL-11268) cells were obtained directly
from ATCC and maintained in high glucose (4 g/L) DMEM
(Corning/Mediatech) supplemented with 10% FBS (Atlanta
Biologicals), 2 mM glutamine (Corning/Mediatech), and 1× Pen/
Strep (Corning/Mediatech) and passaged when ∼85%–90% conflu-
ent. Cells were tested for mycoplasma upon receipt. For experi-
ments, cells were plated on 10 cm dishes (CytoOne, USA
Scientific) in high glucose (4.0 g/L) media and allowed to attach/
recover for 18–24 h. The next day, the media were removed and
replaced with media containing 1 g/L glucose. Hypoxic treatments
were carried out in a Ruskin In Vivo 400 Hypoxia Hood (The
Baker Company) maintained at 37°C, 5% CO2, 70% humidity,
and 1% oxygen. All other chemical reagents were obtained from
Sigma-Aldrich unless otherwise specified.
RNA extraction
TRIzol (Life Technologies) was used for all RNA extractions accord-
ing to the manufacturer’s protocol. RNA was further purified
and treated with RNase-Free DNase I (Life Technologies) using
the PureLink RNA Mini Kit (Life Technologies). For RNA extrac-
tion from ribonucleoprotein immunoprecipitations (RNP-IP) and
sucrose gradients, GlycoBlue (Life Technologies) was added as a
carrier during the precipitation step. RNA quality and quantity
were determined via NanoDrop 1000 (ThermoFisher Scientific).
Poly(A)+ RNA purification
Poly(A)+ RNA was first purified from total RNA through oligo(dT)
selection using a poly(A) Purist-MAGmagnetic mRNA Purification
Kit (Life Technologies), followed by ribosomal RNA depletion using
a RiboMinus Eukaryote Kit (Life Technologies) according to the
manufacturer’s protocols.
LC-MS/MS of poly(A)+ RNA for m6A modification
analysis
Poly(A)+ RNA was hydrolyzed enzymatically by first denaturing the
RNA at 95°C followed by immediate placement on ice. Poly(A)+
RNAwas incubated with S1 nuclease buffer and 1 unit of S1 nuclease
(Life Technologies) per 300 ng of RNA for 30 min at 37°C. Alkaline
phosphatase buffer, 1 unit of alkaline phosphatase per 300 ng of
RNA (Life Technologies), and 0.00025 units of venom phosphodi-
esterase I (Sigma-Aldrich) were added to incubate for 30 min at
37°C. Fragmented RNAwas purified through two rounds of chloro-
form extraction. LC-MS/MS quantification of m6A and adenine was
performed by Craft Technologies. Separations and identification
by LC-MS/MS were performed using a Thermo Finnigan Linear
Ion Trap Quadrapole (LTQ) mass spectrometer utilizing an electro-
spray ionization interface in selected reaction monitoring mode
connected to the Agilent 1100 autosampler and Agilent 1100
HPLC pump system (Agilent). Detection was performed using an
electrospray ionization source operated in positive ion mode.
LC-MS/MS of poly(A)+, total, and ribosomal RNA
for nucleoside modification analysis
Purified RNA was digested to individual nucleosides and modified
nucleosides were quantified as previously described (Gokhale
et al. 2016). Briefly, digestion was performed with nuclease P1
(Sigma, 2U) in buffer containing 25 mM NaCl and 2.5 mM ZnCl2
for 2 h at 37°C, followed by incubation with Antarctic
Phosphatase (NEB, 5U) for an additional 2 h at 37°C. Nucleosides
were then separated and quantified at the Duke Molecular
Physiology Institute using UPLC-MS/MS as previously described
(Basanta-Sanchez et al. 2016), except acetic acid replaced formic
acid in the mobile phase.
Ribosomal subunit separation
Cells grown in normoxic or hypoxic conditions were harvested
in “Buffer A” (35 mM Tris pH 7.5, 70 mM KCL, 9 mM MgCl,
0.1 mM EDTA, 250 mM sucrose, 0.5% sodium deoxycholate, 1%
Triton X-100, 1× protease inhibitors, 1 mM DTT, and RNase
out). Cell lysate was centrifuged for 15 min at 15,000g in a
Beckman TLA 100 rotor. The supernatant was removed to a new
tube and centrifuged in the same rotor at 150,000g for 90 min.
Ribosome pellets were resuspended in “Buffer B” (10 mM Tris
pH 7.5, 500 mM KCL, 10 mM MgCl2 1× protease inhibitors
1 mM DTT and RNase out) and layered on a 12 mL 15%–30%
sucrose gradient in buffer B. The gradient was centrifuged at
86,000g for 14 h in a Beckman SW-41 Ti swinging bucket rotor.
Of note, 1 mL fractions were collected from the top of the gradient
and the positions of the 40S and 60S ribosomal subunits were found
by measuring each fraction at an absorbance at 254 nm. RNA was
isolated from each sample via TRIzol.
m6A mRNA immunoprecipitation (MeRIP)
m6A ribonucleoprotein immunoprecipitation reactions were per-
formed by first isolating poly(A)+ RNA from normoxic and hypoxic
cells. Protein G Dynabeads (Thermo Fisher Scientific) were washed
3× in 1 mL of IPP buffer (10 mM Tris-HCL pH 7.4, 150 mM NaCl,
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0.1% NP-40). Twenty-five microliters of beads were required per
IP. Anti-N6-methyladenosine mouse monoclonal antibody (EMD
Millipore, MABE1006) was added to the beads (5 µg/IP) and
brought up to 1 mL with IPP buffer. As a negative control, beads
without antibody were used as well. Bead mixture was tumbled
for 16 h at 4°C. Beads were washed 5× with IPP buffer and 100 ng
of poly(A)+ RNA was added to the beads along with 1 mM DTT
and RNase out. The mixture was brought up to 500 µL with IPP
buffer. Bead mixture was tumbled at 4°C for 4 h. Beads were washed
2× in IPP buffer, placed into a fresh tube, and washed 3× more in
IPP buffer. m6A RNA was eluted off the beads by tumbling 2×
with 125 µL of 25 mg/mL N6-methyladenosine-5′-monophosphate
sodium salt (Chem-Impex International Inc.). Supernatant was
added to TRIzol-LS followed by RNA isolation as per manufactur-
er’s protocol. The final RNA sample was brought up in 10 µL of
water.
PCR for MeRIP
Reverse transcription was performed on 10 µL m6A poly(A)+ RNA
from the MeRIP with the iScript cDNA Synthesis Kit (Bio-Rad
Laboratories). After diluting cDNA twofold, quantitative real-time
PCR was performed using a Roche Lightcycler 96 with Fast Start
Essential DNA Green (Roche Diagnostics Corporation) and primers
from Integrated DNA Technologies, Inc. Primers used are listed in
Supplemental Table 1. Primer efficiency was verified to be over 95%
for all primer sets used. Quantification of mRNA from the MeRIP
was carried out via ΔΔCT analysis against nonimmunoprecipitated
input RNA and RNA pulled down from non-antibody bound beads.
All real-time PCR primer sets were designed so the products would
span at least one intron (>1 kb when possible), and amplification of
a single product was confirmed by agarose gel visualization and/or
melting curve analysis.
siRNA transfections
Either a negative siRNA (Silencer; Life Technologies) or METTL3
and METTL14 siRNAs (Qiagen) transfected together using a
Lipofectamine RNAi Max 54 µL/plate as per manufacturer’s proto-
col (Life Technologies) using a 180 pM siRNA/10 cm dish. siRNAs
used can be found in Supplemental Table 2. Cells were incubated for
48–72 h post-transfection with the last 24 h in either normoxic or
hypoxic conditions.
4sU
mRNA half-life determinations using 4sU were performed as per
established protocol (Dölken et al. 2008). Cells were treated with
200 µM 4sU (Sigma-Aldrich) for 1 h. RNA isolated via TRIzol
was biotinylated by labeling 50 µg RNA in a reaction mixture with
50 µL 10× Tris/EDTA buffer (TE), 100 µL 1 mg/mL Biotin-HPDP
(EZ-Link Biotin HPDP, Thermo Scientific) in dimethylformamide
(DMF), and RNase-free H2O brought to 400 µL. The mixture was
incubated in the dark with rotation for 1.5 h. Biotinylated RNA
was extracted using an equal volume of Chloroform/Isoamyl alcohol
(24:1) 2× in phase lock gel heavy tubes (5 Prime) followed by RNA
precipitation with isopropanol. RNA was heated to 65°C for 10 min
and placed immediately on ice. RNA was added to Dynabeads
MyOne Streptavidin C1 (Thermo Fisher Scientific) that had been
thoroughly washed and resuspended in 2× streptavidin binding
buffer (2× TE, 2 M NaCl). The RNA bead mixture was incubated
with rotation for 30 min. Beads were washed 5× with 65°C wash
buffer (1× TE, 1 M NaCl, 0.1% Tween20) and the supernatant
was kept containing the nonlabeled RNA. Three rounds of 100
mM dithiothreitol (DTT) elution followed by one round of TE elut-
ed labeled RNA from the beads. RNA was isolated via Isopropanol
and resuspended in 40 µL of water.
mRNA half-life
mRNA levels were determined by real-time quantitative PCR using
1 µL of RNA from both labeled and unlabeled 4sU samples. Decay
rates were calculated by the natural log of one minus the RNA input
normalized ratio of labeled over unlabeled RNA. All half-lives were
normalized to GAPDH half-life which was defined as 8 h based on
previous publications and our unpublished data (Payne et al. 2014).
Polysome profiling
Cells were treated with 200 µM cyclohexamide for 15 min prior to
harvest. Cells were harvested in PLB buffer (100 mM KCl, 5 mM
MgCl2, 10 mM Hepes, 0.5% NP40, 200 µM cyclohexamide, 1mM
DTT, 1× protease inhibitors, RNase out) and incubated on ice for
30 min. Lysates were precleared by centrifugation for 8 min at
5000g. Supernatant was layered on a 10%–45% sucrose gradient
in polysome profile buffer (300 mM KCl, 50 mM Hepes, 10 mM
MgCl2, 200 µM cyclohexamide). The gradient was centrifuged at
38,000g for 1 h 45 min in a Beckman SW-41 Ti swinging bucket
rotor. Twelve 1 mL fractions were collected from the top of the
gradient and the polysomes were measured from lightest to heaviest
at an absorbance at 254 nm. RNA was isolated from each sample
using TRIzol.
Profiling PCR
Reverse transcription was performed on 1 µL of RNA from each
fraction in a 20 µL reaction. After diluting cDNA fivefold, quantita-
tive real-time PCR was performed. Percentages of mRNA per frac-
tion was carried out via ΔCT analysis using a baseline Cq value
representing 0%mRNA. Percentage of ribosomal RNAwas calculat-
ed in the same manner.
Western blots
Whole-cell lysates were prepared in whole-cell extract buffer
(WCEB: 50 mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, 0.1%
SDS, and complete protease inhibitor [Promega]). Equal amounts
of protein (30–50 μg) were electrophoresed on a mini-PROTEAN
any KD acrylamide gel (Bio-Rad Laboratories) and transferred to
Hybond ECL nitrocellulose (GE Healthcare). The transfer was ver-
ified via Ponceau S staining, then the blot was blocked with 5% non-
fat dry milk (LabScientific) in Tris-buffered saline with 0.1% Tween
20 (TBST) for 1 h at room temperature, followed by primary anti-
body in blocking buffer overnight at 4°C. After washing extensively
with TBST, blots were incubated for 1–2 h at room temperature with
appropriate HRP-linked secondary antibody (GE Healthcare),
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washed again with TBST, developed using Pierce ECL Western
Blotting Substrate (ThermoFisher Scientific), and exposed to film
for detection. Primary Antibodies used and their concentrations
can be found in Supplemental Table 3.
Statistical analysis
All experiments were performed on at least three separate occasions
to generate biological replicates unless otherwise indicated. qPCR
was performed at least twice on each cDNA for technical verification
of data. Half-lives were calculated for each biological replicate and
then averaged together to determine final value and standard error
of the mean. Statistical significance was calculated by a two-tailed,
paired Student’s t-test comparing experimental to control condi-
tions. A P-value below 0.05 was defined as statistically significant.
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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